Concepedia

M. Cannell

MC

Statistics

Publications

3

Citations

107

H-Index

3

Active since

2018

Affiliations

Acceleron Pharma (United States)(Current)

M. Cannell is an author at Acceleron Pharma (United States) specializing in molecular physiology, cytoskeleton, and cell signaling.

Top concepts

Publications per year

2018–2021

3

Publications

3

Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease

R. Scott Pearsall, Monique V. Davies, M. Cannell et al. · Scientific Reports · 2019 · 49 citations · Full text

ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

Jia Li, Maureen Fredericks, M. Cannell et al. · Journal of Clinical Investigation · 2021 · 32 citations · Full text

Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle

Roselyne Castonguay, Jennifer Lachey, Samantha Wallner et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 26 citations · Full text

, , +12

Rows per page

1–3 of 3